IRIS
BIAMONTE, FLAVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.846
AS - Asia 853
EU - Europa 587
SA - Sud America 154
Continente sconosciuto - Info sul continente non disponibili 132
AF - Africa 26
OC - Oceania 5
AN - Antartide 1
Totale 3.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.767
SG - Singapore 379
IT - Italia 337
CN - Cina 206
BR - Brasile 117
VN - Vietnam 81
IN - India 77
DE - Germania 61
CA - Canada 47
HK - Hong Kong 42
GB - Regno Unito 38
SE - Svezia 36
FI - Finlandia 23
ES - Italia 15
BD - Bangladesh 14
IQ - Iraq 13
UA - Ucraina 13
AR - Argentina 12
MX - Messico 12
NL - Olanda 11
CZ - Repubblica Ceca 9
EC - Ecuador 8
FR - Francia 8
ZA - Sudafrica 8
CL - Cile 6
CR - Costa Rica 6
TR - Turchia 6
AT - Austria 5
PK - Pakistan 5
AU - Australia 4
CH - Svizzera 4
CO - Colombia 4
ID - Indonesia 4
JM - Giamaica 4
JP - Giappone 4
PL - Polonia 4
SC - Seychelles 4
IE - Irlanda 3
IR - Iran 3
PA - Panama 3
RO - Romania 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BS - Bahamas 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
PY - Paraguay 2
UY - Uruguay 2
VE - Venezuela 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.476
Salva come PNG Salva come JPEG
Città #
San Jose 313
Dallas 186
Chandler 181
Ashburn 169
Singapore 156
Santa Clara 77
Council Bluffs 70
Bengaluru 61
Catanzaro 60
Hefei 58
Milan 54
Munich 48
Princeton 43
Los Angeles 42
Ho Chi Minh City 38
Hong Kong 38
Beijing 37
Lawrence 37
Boardman 36
London 29
Chicago 25
São Paulo 23
Phoenix 22
Wilmington 21
Turku 19
Naples 14
New York 14
Ottawa 13
Des Moines 11
Hanoi 11
Montreal 9
Rome 9
Toronto 9
Brooklyn 8
Olomouc 8
Orem 8
Shanghai 8
Atlanta 7
Baghdad 7
Caserta 7
Denver 7
Hanover 7
Palermo 7
Washington 7
Boston 6
Maryland Heights 6
Reggio Calabria 6
San Francisco 6
Aversa 5
Haiphong 5
Bari 4
Cosenza 4
Englewood 4
Guangzhou 4
Helsinki 4
Johannesburg 4
Kyiv 4
Lamezia Terme 4
Mexico City 4
Pune 4
Rio de Janeiro 4
San José 4
Stockholm 4
The Dalles 4
Tokyo 4
Belo Horizonte 3
Bologna 3
Charlotte 3
Chennai 3
Columbus 3
Dhaka 3
Dublin 3
Las Rozas de Madrid 3
Manaus 3
Marseille 3
Montalto Uffugo 3
Newark 3
Paola 3
Pistoia 3
Rende 3
Rosarno 3
Tashkent 3
Troina 3
Volta Redonda 3
Warsaw 3
Zurich 3
Addis Ababa 2
Amsterdam 2
Andover 2
Ann Arbor 2
Assago 2
Augusta 2
Barcelona 2
Biên Hòa 2
Bridgetown 2
Brisbane 2
Cape Town 2
Carapicuíba 2
Da Nang 2
Daegu 2
Totale 2.199
Salva come PNG Salva come JPEG
Nome #
COVID-19: high-JAKing of the inflammatory “flight” by ruxolitinib to avoid the cytokine storm 96
FtH-Mediated ROS Dysregulation Promotes CXCL12/CXCR4 Axis Activation and EMT-Like Trans-Differentiation in Erythroleukemia K562 Cells 93
Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis 91
H-Ferritin Affects Cisplatin-Induced Cytotoxicity in Ovarian Cancer Cells through the Modulation of ROS 91
IL-20 Subfamily Biological Effects: Mechanistic Insights and Therapeutic Perspectives in Cancer 86
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. 86
H ferritin silencing induces protein misfolding in K562 cells: A Raman analysis 85
Gene expression analysis of autofluorescence margins in leukoplakia and oral carcinoma: a pilot study 83
Chemoresistance in H-Ferritin Silenced Cells: The Role of NF-κB 81
H-ferritin-regulated MicroRNAs modulate gene expression in K562 cells 77
MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer. 75
Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis 74
Ferritin Heavy Chain Binds Peroxiredoxin 6 and Inhibits Cell Proliferation and Migration 71
Caffeine Positively Modulates Ferritin Heavy Chain Expression in H460 Cells: Effects on Cell Proliferation. 71
Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response 70
SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma 69
Expulsion of iron-rich ferritin via CD63-mediated exosome drives ferroptosis resistance in ovarian cancer cells 68
Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma 67
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 67
Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells 67
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 67
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 66
Uncovering the metabolic and stress responses of human embryonic stem cells to FTH1 gene silencing 63
shRNA targeting of ferritin heavy chain activates H19/miR-675 axis in K562 cells. 61
Editorial: New strategies to tackle chemoresistance in cancer 60
Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing 59
Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression 59
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 57
The Double-Edged Sword of Oleuropein in Ovarian Cancer Cells: From Antioxidant Functions to Cytotoxic Effects 57
FTH1 Pseudogenes in Cancer and Cell Metabolism 57
Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing. 56
Ferroptosis and Cancer: Mitochondria Meet the "Iron Maiden" Cell Death 56
Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene. 56
Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions 55
Severe and mild-moderate SARS-CoV-2 vaccinated patients show different frequencies of IFNγ-releasing cells: An exploratory study 54
Novel insights into the pharmacological modulation of human periodontal ligament stem cells by the amino-bisphosphonate Alendronate. 53
Human haematological and epithelial tumor-derived cell lines express distinct patterns of onco-microRNAs 53
Characterisation and discovery of novel miRNAs andmoRNAs in JAK2V617F mutated SET2 cells 53
FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation. 51
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy 50
Innovative experimental approach for the morphological characterization of cancer stem cells spheroids 49
Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: Identification of gain-of-function mutations in the RET proto-oncogene 48
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 47
Overcoming BET‐inhibitor JQ1 resistance in aggressive non‐small cell lung cancer by inducing ferroptosis via inhibition of the BRD2–FTH1 axis 47
Ferroptosis and oral squamous cell carcinoma: connecting the dots to move forward 46
EZH2 mutational status predicts poor survival in myelofibrosis 46
Epigenetics and mutations in chronic myeloproliferative neoplasms 45
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 43
Acute Exposure to Cadmium Triggers NCOA4-Mediated Ferritinophagy and Ferroptosis in Never-Smokers Oral Cancer Cells 38
Human haematological and epithelial tumor-derived cell lines express distinct patterns of onco-microRNAs. 37
Iron Fist in a Velvet Glove: Class IV Ferroptosis Inducers as a Novel Strategy to Target Ovarian Cancer 37
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis 36
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 35
Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease 35
Editorial: Molecular and cellular mechanisms for cancer therapy resistance 34
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms 34
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis 34
Profilin 1 deficiency drives mitotic defects and reduces genome stability 33
The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis 31
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients 30
Mutations and prognosis in primary myelofibrosis 28
Diagnostic Performance of Autofluorescence for Oral Lesions: A Comparison Between a Postgraduate and an Expert Clinician 27
Interaction of Ferroptosis and Immune-Mediated Inflammation in Psoriasis 16
Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer 16
Probing the Effects of Plasma-Treated Water Solutions on Healthy and Head and Neck Cancer Cells via FTIR and Raman Spectroscopy 10
Correction to: Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: Identification of gain-of-function mutations in the RET proto-oncogene (Journal of Experimental and Clinical Cancer Research (2018) 37 (84) DOI: 10.1186/s13046-018-0746-y) 9
null 2
Totale 3.604
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.062
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022167 0 0 0 29 11 8 6 36 9 36 21 11
2022/2023406 83 49 8 34 48 29 7 39 54 14 29 12
2023/2024213 33 20 17 28 14 30 13 4 4 4 11 35
2024/2025653 81 19 18 47 50 92 10 28 78 12 109 109
2025/20261.582 113 229 166 201 148 70 197 73 172 151 51 11
2026/2027422 21 94 216 91 0 0 0 0 0 0 0 0
Totale 3.604